References
- Forbes BA, Hall GS, Miller MB, et al. Practice guidelines for clinical microbiology laboratories: mycobacteria. Clin Microb Rev. 2018; 31:e00038–17.
- Storla DG, Yimer S, Bjune GA. A systematic review of delay in the diagnosis and treatment of tuberculosis. BMC Pub Health. 2008;8:15.
- Shinnick TM, Iademarco MF, Ridderhof JC. National plan for reliable tuberculosis laboratory services using a systems approach. Recommendations from CDC and the association of public health laboratories task force on tuberculosis laboratory services. The Morbidity and Mortality Weekly Report. 2005;54(RR-6):1–12.
- Alisjahbana B, van Crevel R, Danusantoso H, et al. Better patient instruction for sputum sampling can improve microscopic tuberculosis diagnosis. Int J Tubercul Lung Dis. 2011;9:814–817.
- Haumba S, Dlamini T, Calnan M, et al. Declining tuberculosis notification trend associated with strengthened TB and expanded HIV care in Swaziland. Public Health Action. 2015;5(2):103–105.
- Sibbald B. Responding to Swaziland's dual epidemic. CMAJ. 2013;185(1):E13–E14.
- Sanchez-Padilla E, Merker M, Beckert P, et al. Detection of drug-resistant tuberculosis by Xpert MTB/RIF in Swaziland. N Engl J Med. 2015;372(12):1181–1182.
- Meyer AJ, Atuheire C, Worodria W, et al. Sputum quality and diagnostic performance of GeneXpert MTB/RIF among smear-negative adults with presumed tuberculosis in Uganda. Pub Lib Sci Med. 2017;12(7):e0180572.
- Cepheid. 2017. Launch of new TB test Ultra backed by WHO recommendation. [cited 2020 Sept 05]. Available from: www.cepheid.com/us/about-us/news-events/press-releases
- Steingart KR, Schiller I, Horne DJ, et al. GeneXpert MTB/RIF (Cepheid, Sunnyvale, CA, USA) assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev. 2014;1:CD009593.
- Central statistics and population’s office. 2019. Ministry of Home Affairs, Eswatini. [cited 2020 Sept 8].
- Ho J, Nguyen PTB, Nguyen TA, et al. The role of macroscopic sputum quality assessments to optimise sputum testing for tuberculosis. Int J Tuberc Lung Dis. 2016;20(3):319–322.
- Zimba O, Tamuhla T, Basotli J, et al. The effect of sputum quality and volume on the yield of bacteriologically-confirmed TB by xpert MTB/RIF and smear. Pan Afr Med J. 2019;33:110.
- Orina F, Mwangi M, Githui W, et al. Effect of sputum quality on GeneXpert MTB/RIF (Cepheid, Sunnyvale, CA, USA) results in the detection of Mycobacterium tuberculosis from persons presumed to have tuberculosis in EAPHLN project operational research study sites in Kenya. Afr J Health Sci. 2014;27(4):446–456.
- Fløe A, Hilberg O, Thomsen VØ, et al. Shortening isolation of patients with suspected tuberculosis by using polymerase chain reaction analysis: a nationwide cross-sectional study. Clin Infect Dis. 2015;61(9):1365–1373.
- Rajagopalan S, Yoshikawa T, Nahimo N. Tuberculosis in the elderly. Z Gerontol Geriatr. 2000;33(5):374–380.
- Karigeni T. Southern Africa Tackles Tuberculosis in the Mining Industry. World bank report; 2014.
- Uplekar M, Wells WA, Pai M. Achieving systemic and scalable private sector engagement in tuberculosis care and prevention in Asia. Pub Lib Sci Med. 2015;12(6):e1001842.
- Ventura E. United Nations Migration Health. TB and migration in Southern Africa; 2016. p. 1–4.